Practice-changing use of the 21-gene oncotype DX breast recurrence score test in Latin American hospitals.

被引：0

作者：

Leonidas Gomez, Henry

Enrique Bargallo-Rocha, Juan

Jorge Billinghurst, Roberto

Nunez de Pierro, Anibal Roberto

Andres Colo, Federico

Benitez Gil, Lisandro Luis

Allemand, Carola

Leonardo McLean, Ignacio

Lema-Medina, Mauricio

Herazo-Maya, Fernando

Jose Terrier, Francisco

Gerson Cwilich, Raquel

Leon Rivera, Mauricio

Gabriela Falcon, Silvia

Eduardo Castano, Roberto

Cordeiro Oliveira, Sergio

Jakubowski, Debbie M.

Chao, Calvin Y.

机构：

[1] Oncosalud Auna, Lima, Peru

[2] Inst Nacl Cancerol, Mexico City, DF, Mexico

[3] Sanatorio Mater Dei, Buenos Aires, DF, Argentina

[4] Hosp Dr Juan A Fernandez, Buenos Aires, DF, Argentina

[5] Inst Alexander Fleming, Buenos Aires, DF, Argentina

[6] Ctr Mastol, Rosario, Argentina

[7] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina

[8] Hosp Univ Austral, Buenos Aires, DF, Argentina

[9] Clin Oncol Astorga, Medellin, Colombia

[10] Breast Clin Mama, La Plata, Argentina

[11] Hosp Italiano La Plata, La Plata, Argentina

[12] Ctr Med ABC, Mexico City, DF, Mexico

[13] Clin Ricardo Palma, Lima, Peru

[14] Ctr Oncol, Aliada, Lima, Peru

[15] Hosp Aleman Buenos Aires, Buenos Aires, DF, Argentina

[16] Exact Sci Corp, Redwood City, CA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e12539

引用

页数：2

共 50 条

[1] Practice-changing use of 21-gene oncotype DX breast recurrence score assay in a public hospital in Brazil: Results of 155 cases.
Mattar, Andre
Fonseca, Guilherme Ribeiro
Agudo Romao, Murilo Barato
Shida, Jorge Yoshinori
Agata Stiepcich, Monica Maria
Jakubowski, Debbie M.
Chao, Calvin Y.
Oliveira, Sergio C.
Gebrim, Luiz Henrique
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[2] Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting
Robidoux, A.
McCullough, D.
Lau, A.
Stoppler, M.
Chao, C.
BREAST, 2017, 32 : S80 - S80
[3] Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America
Gomez, Henry L.
Bargallo-Rocha, Juan E.
Billinghurst, Roberto J.
De Pierro, Anibal R. Nunez
Colo, Federico A.
Gil, Lisandro L. B.
Allemand, Carola
McLean, Ignacio L.
Lema-Medina, Mauricio
Herazo-Maya, Fernando
Terrier, Francisco J.
Cwilich, Raquel G.
Leon, Mauricio
Falcon, Silvia G.
Castano, Roberto E.
Oliveira, Sergio C.
Jakubowski, Debbie M.
Chao, Calvin
JCO GLOBAL ONCOLOGY, 2021, 7 : 1364 - 1373
[4] Oncotype DX 21-gene test has a low recurrence score in both pure and mixed mucinous breast carcinoma
Chen, Rui
Wang, Yun
Li, Taolang
Lv, Junyuan
Feng, Guoli
Tan, Na
Wang, Jinjing
Cheng, Xiaoming
ONCOLOGY LETTERS, 2021, 22 (05)
[5] 21-Gene Oncotype DX® Recurrence-Score benefits and application in elderly breast cancer patients
Chiru, E. D.
Kuhar, C. Grasic
Oseledchyk, A.
Kurzeder, C.
Vetter, M.
SWISS MEDICAL WEEKLY, 2022, 152 : 43S - 43S
[6] Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer
Lashen, A. L.
Toss, M. T.
Fadhil, W. F.
Oni, G. O.
Madhusudan, S. M.
Rakha, E. R.
JOURNAL OF PATHOLOGY, 2023, 261 : S10 - S10
[7] Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer
Chen, Clara
Dhanda, Rahul
Tseng, Wan-Yu
Forsyth, Michael
Patt, Debra A.
JOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (04) : 182 - +
[8] Is the 21-gene Breast Cancer Test (Oncotype DX®) Good Value for Money?
Pronzato, P.
Plun-Favreau, J.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S388 - S388
[9] Is the 21-Gene Breast Cancer Test (Oncotype DX®) Cost-Effective?
Pronzato, P.
Plun-Favreau, J.
CANCER RESEARCH, 2011, 71
[10] Evaluation oncotype DX® 21-gene recurrence score and clinicopathological parameters: a single institutional experience
Lashen, Ayat
Toss, Michael S.
Fadhil, Wakkas
Oni, Georgette
Madhusudan, Srinivasan
Rakha, Emad
HISTOPATHOLOGY, 2023, 82 (05) : 755 - 766

← 1 2 3 4 5 →